Marine Mazzenga Selected Research

Infections

10/2022	Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
1/2022	The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
12/2021	Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marine Mazzenga Research Topics

Disease

4	Neoplasms (Cancer) 10/2022 - 12/2021
3	Infections 10/2022 - 12/2021
2	COVID-19 01/2022 - 12/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022
1	Tertiary Lymphoid Structures 10/2022
1	Dysbiosis 01/2022
1	Atrophy 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Lymphopenia (Lymphocytopenia) 12/2021

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 10/2022
1	ChemokinesIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	pembrolizumabIBA 10/2022
1	AndrogensIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	VaccinesIBA 01/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	AntibodiesIBA 12/2021
1	Viral RNAIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	Granzymes (Granzyme)IBA 12/2021

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2021
1	Immunomodulation 10/2022
1	Castration 01/2022